Clinical trial
Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Opening soon · Not applicable · 0 countries · Registry ID NCT07451366
Opening soonNot applicableObservational
What this study is about
Our study will assess the prevalence of obesity among patients with (MASLD) and to evaluate the characteristics of lean MAFLD patients.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to 60 Years
SexAll
Healthy volunteersAccepted
ConditionLean MASLD
Full registry criteria
Inclusion Criteria: * All patients aged \>18 years old * diagnosed as fatty liver based on clinical examination, laboratory investigations and imaging techniques Exclusion Criteria: * Patients aged ≤18 years old. * Pregnancy. * Presence of malignancy * Type I DM. * Fatty liver patients on treatment by statin derivatives or other medications. * Fatty liver patients undergone bariatric surgerie
Treatments and study arms
The registry does not list a named intervention.
Primary outcomes
Prevalence of Obesity and Clinical Characteristics of Lean MASLD Patients24 month
This study aims to assess the prevalence of obesity among patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and to evaluate the demographic, clinical, and metabolic characteristics of lean MASLD patients
Study locations
0 locations were listed when this page was built. The first 40 are shown.
No public site location was included in this record. Check the original registry for updates.